| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Lee Frank D. serves as a Chief Executive Officer at PCRX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 2 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | BHC Bausch Health Companies Inc. | Director | Sell10b5-1 | 24,456 | $5.43 | $132,796.08 | -33.1% | +23.7% | - | |
| Aug 21, 2025 | BHC Bausch Health Companies Inc. | Director | Sell | 15,912 | $7.66 | $121,885.92 | -17.7% | -19.3% | -14.1% | |
| Aug 12, 2024 | PCRX Pacira Biosciences, Inc. | Chief Executive Officer | Buy | 8,264 | $12.10 | $99,994.40 | +8.3% | +42.4% | +101.9% |